New Products In Brief
This article was originally published in The Tan Sheet
Executive Summary
Chloraseptic pops out line extensions
You may also be interested in...
In Brief
Novartis appeals Excedrin case to NARB
New Products In Brief
Splenda Essentials SKUs get functional
Developing Antitussive Alternatives To DXM Would Offset Commercial Risk
Expert advisors to FDA encourage firms to develop new OTC cough suppressants to replace dextromethorphan, which some argue is ineffective and poses an abuse risk